Legend Capital

Legend Capital, founded in 2001 as a subsidiary of Legend Holdings Ltd., is a prominent asset manager based in China. With a focus on private equity investments, the firm manages approximately $700 million across four funds and specializes in early-stage and mid-market growth ventures. Its investment strategy primarily targets high-growth companies with significant operations in China or related markets, particularly in sectors such as information technology, consumer goods, clean technology, healthcare, and equipment manufacturing. Legend Capital is known for its active involvement with portfolio companies, providing comprehensive business resources and tailored services to enhance business development and company visibility in the Chinese market. The firm’s portfolio includes notable companies like Joyo.com, SinoCom, and Solarfun Power, reflecting its commitment to driving innovation and value creation within China's venture capital landscape.

Raymond Chen

Co-chief Investment Officer

Arthur Ge

Managing Director

Frank Hong

Managing Director

Richard Li

President

Bibo Peng

VP

Jenking Shao

Managing Director

Piau Voon Wang

Managing Director and Chief Operating Officer

Jafar Wang

Co-CIO / MD

Hank Zhou

Executive Director

Past deals in Growth Stage

Bio-Engine

Series C in 2023
Bio-Engine engages in research and development of veterinary biological products. The company develops and manufactures antibodies, recombinant proteins, human and livestock virus vaccines through serum free suspension of animal cells. The company also provide clinical trial services for pharmaceutical manufacturers and scientific research units. The company was founded in 2014 and is headquartered in Shanghai, China.

Tripod Preclinical Research

Funding Round in 2023
Tripod is a Contract Research Organization in the biopharmaceutical space that provides preclinical research services for global pharma companies, R&D enterprises and institutes, and medical device developers. Tripod (TPR) is dedicated to nonclinical research (drug safety evaluation) for the candidates of new chemical entity (NCE), food additives, biologics,pesticides,veterinary drugs, and new cosmetics.

ZStack

Series C in 2023
ZStack Cloud Platform has served more than 1,000 enterprise users and established ecological and channel partnerships with more than 200 cloud vendors, covering government, finance, education, internet, energy, manufacturing and many other industries.

Ruicycle

Series B in 2022
Ruicycle is a high-tech company that focuses on the comprehensive recycling and utilization of lithium batteries.

Tianfu

Series C in 2022
Nanjing Tianfu Software Co., Ltd. develops custom software solutions for various industries, such as turbomachinery, hydraulic construction, automotive, aerospace, and shipbuilding. The company founded in 2011 and is based in Nanjing, China.

TBSTest

Venture Round in 2022
TBSTest Technology is a developer and manufacturer of integrated circuit automatic test equipment, specializing in solutions for semiconductor manufacturers. Founded in 2017 and headquartered in Beijing, China, with additional offices in Xi’an City, Shanghai, and Suwon, South Korea, the company offers a range of products including test boards, software solutions, and memory systems. TBSTest Technology also provides pre-sales and after-sales support for its equipment, accessories, and software systems, catering to clients in integrated circuit design and production, as well as scientific research institutions and educational organizations. The company is dedicated to advancing testing technology for ultra-large-scale integrated circuits, ensuring high-quality performance for enterprise users in the semiconductor industry.

Lipinyun

Series B in 2022
Lipinyun is a tencent strategic investment company. They offer a full-process intelligent sales model, from customer acquisition and screening to customer management and digital asset accumulation, for enterprises diverse sales ecology. Their integration solution helps enterprises realize the upgrade and iteration of digital business.

Qingwei Intelligent Technology

Series B in 2022
Qingwei Intelligent Technology is a Chinese artificial intelligence (AI) chip maker

Medilink Therapeutics

Series B in 2022
MediLink Therapeutics has established its R&D center in Suzhou, China. The company focuses on developing next generation drug conjugates, and aims to serve the vast unmet medical needs in China, and create global value through conducting multicenter clinical trials and cross-border collaborations.

Inceptio Technology

Series B in 2022
Inceptio Technology (Shanghai) Co., Ltd. is an autonomous trucking start-up based in Jiangxi, China, founded in 2018. The company specializes in transforming line-haul logistics through a nationwide freight network that employs autonomous heavy-duty trucks. By leveraging artificial intelligence, new energy technology, and logistics big data, Inceptio Technology aims to enhance the security, efficiency, and cost-effectiveness of transportation services for logistics customers. Its focus on providing transportation-as-a-service positions it to meet the evolving needs of the logistics industry while promoting safer and more efficient freight solutions.

Hoteam Software

Series C in 2022
Shandong Hoteam Software Co., Ltd, established in 1993 and based in Jinan, China, specializes in developing software products for the manufacturing sector. As a subsidiary of China Aerospace Science and Technology Corporation, the company focuses on providing industrial enterprises with comprehensive 3D-centric intelligent manufacturing solutions. Its software platforms encompass three-dimensional design, intelligent management, and visualization technologies, which aim to enhance work efficiency and reduce operational costs for clients engaged in collaborative research and development.

Singlomics

Series B in 2022
Singlomics uses single-cell sequencing technology to develop antibody drugs for the treatment of infectious diseases and cancers.

Zshield

Series C in 2022
ZShield Inc. provides cyberspace data security and big data business risk management. The company offers production innovation and data security services, information security platform, and AndunTM ZS-ISP which helps government and enterprises. The company was founded in 2014 and is based in Beijing, China.

Beijing Tianxing

Series B in 2022
Beijing Tianxing is a clinical solutions company for sports medicine for implants, arthroscopy devices, and sports medicine equipment.

Leapstack

Series C in 2021
Leapstack is an insurance technology company specializing in big data artificial intelligence technology. It is committed to building big data artificial intelligence solutions for commercial insurance companies and social security management agencies. The company was founded in February 2016 and has received angels from Gaochun Capital and Fumu Assets. It is headquartered in Shanghai and has offices in Beijing and Nanjing.

Xbiome

Series B in 2021
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

ColorTech Bio

Series B in 2021
ColorTech Bio researches and develops precision molecular diagnostic equipment. It offers medical devices to improve biotechnology services and solutions. ColorTech Bio was founded in 2018 and is based in Suzhou, China.

River Security

Series C in 2021
Silicon Security, founded in 2012, focuses on providing the industry's cutting edge Internet dynamic application security solution. Headquartered in Shanghai, Beijing and Shenzhen, respectively, with branches, and set up a research and development center in Chengdu. Ruimin information after more than two years of research and development, developed a global leader in the leading active defense security technology. The technology completely subvert the traditional continuation of more than 20 years of security technology base, can defend against a variety of unknown modern means of attack, blocking more efficient, more timely, while significantly reducing deployment and use costs.

Jifan Biotechnology

Series B in 2021
Jifan Biotechnology is a biotechnology firm that provides molecular biology reagents, diagnostic raw materials, and kits for research.

Wuxi Biortus Biosciences

Series B in 2021
Wuxi Biortus Biosciences Co. Ltd. is a contract research organization that provides research and development services in support of drug discovery. Its services include recombinant protein production; in vitro assays and screening; medicinal chemistry; structural biology; and target validation. The company was founded in 2009 and is based in Jiangyin, China. Wuxi Biortus Biosciences Co. Ltd. operates as a subsidiary of Jiangsu Shuangliang Group Company Ltd.

H.Extract

Series C in 2021
H.Extract, established in 2010 and based in Qingdao, China, specializes in producing natural extracts from various spices such as pepper, ginger, garlic, and cumin for the food manufacturing sector. The company focuses on the research and development of high-quality extracts to meet the needs of food producers, enhancing flavor and nutritional value in their products. H.Extract is committed to maintaining industry standards and ensuring customer satisfaction through its innovative solutions and dedication to quality. With a growing reputation in the market, the company continues to expand its product offerings and strengthen its position within the food industry.

HC Scientific

Series B in 2021
HC Scientific Technology Co., Ltd. is a company based in Chengdu, China, that specializes in the development, manufacturing, and distribution of genetic testing instruments, reagents, and software. Founded in 2015, the company serves various sectors, including clinical molecular diagnostics, health genetic testing, and agricultural molecular breeding, both domestically and internationally. HC Scientific's product lineup features instruments such as the Matrix Arrayer for reaction plate preparation, the Matrix Cycler for thermal cycling, and the Matrix Scanner for fluorescence detection. Additionally, the company provides consumables like the Matrix plate and Matrix Mix genotyping reagents, along with a data management system known as Matrix Master. Committed to innovation, HC Scientific focuses on autonomous research and development of its intellectual property, aiming to deliver high-throughput, automated, and cost-effective genetic testing solutions.

LYNK Pharmaceuticals

Series B in 2021
LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.

Berry Oncology

Series B in 2021
Berry Oncology develops medical technology intended to improve cancer prevention and tumor diagnosis. It offers genetic diagnosis solutions from early diagnosis to mid-late monitoring that can solve clinical problems in the direction of several malignant tumors, providing patients with a higher quality of life and reduced risk of cancer. The company's mission is early diagnosis and early treatment of all tumors, all patients receive precise treatment. Along with its vision to become a global icon in the field of early screening and early diagnosis of tumors and a leader in China's tumor gene testing market.

Mathpresso, Inc.

Series C in 2021
Mathpresso, Inc. is an educational technology company based in Seoul, South Korea, established in 2015. It operates Qanda, a data-driven platform that leverages artificial intelligence and optical character recognition (OCR) technology to assist students with their studies. Users can take a photo of a question or problem, which the platform then analyzes to provide solutions and explanations. Qanda covers a wide range of subjects, including mathematics, Korean history, social studies, and science. The platform is designed to facilitate learning by allowing students to engage with tutors and access answers in real time. As of this year, Qanda has attracted over one million users in South Korea, making it a significant resource for students seeking help with homework and exam preparation.

Horizon Robotics

Series C in 2021
Beijing Horizon Robotics Technology Co., Ltd. develops chips for robots. The company was founded in 2015 and is based in China.

Bruco Group

Series B in 2021
Bruco uses innovative technology to create the ultimate product experience and create long-term value for users. The group currently has four core business segments, including Bruker Building Blocks, Bruker Animation, Bubble Education, and Brock Education. Bruco strives to create a whole ecological industry chain with "building blocks +" as the core, and at the same time applies to build blocks to various application scenarios, and lays out a complete T (Toy toy) + A (Animation animation) + G (Game game) +E (Education Education) industry vision.

Fiture

Series B in 2021
Fiture, a fitness technology company, is redefining the home fitness scenarios through intelligent hardware and AI-empowered fitness content.

StoneWise

Series B in 2021
Beijing StoneWise Technology Co., Ltd. operates as a technology company that engages in the research and development (R&D) of artificial intelligence-driven drug design solutions for drug R&D enterprises and institutions. Its drug discovery platform focuses on the investigation and repurpose of nucleoside-based RNA polymerase inhibitors and their potential use in COVID-19 infection treatment. The company was founded in 2018 and is based in Beijing, China.

Sciwind Biosciences

Series B in 2021
Hangzhou Sciwind Biosciences Co., Ltd. develops and sells protein/peptide drugs for treating diseases in multiple therapeutic areas, including diabetes, obesity, metabolic liver diseases, diabetic retinopathy/macular edema, and neuro-degenerative diseases. The company was founded in 2017 and is based in Hangzhou, China.

Liangyihui

Series C in 2021
Suzhou Liangyihui Network Technology Co., Ltd. develops anti-cancer academic platform for cancer patients. The company is based in Shanghai, China.

Exegenesis Bio

Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.

Wangdiantong

Series C in 2020
Wangdiantong ERP is an enterprise-level e-commerce ERP, supporting Taobao, Tmall, Jingdong, Amazon, Dangdang, No. 1 shop, Alibaba and many other platforms, supporting multi-warehouses, support online stores and physical store cashiers. Including goods management, inventory, orders, purchasing, after-sales, accounts, statistics, CRM and other rich features.

Xbiome

Series B in 2020
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

GalaxySpace

Series C in 2020
GalaxySpace develops and builds LEO broadband satellite constellation, and 5G communication network. The company’s satellite applications include monitoring of airport, parking, and oil reserves, as well as assess land types and uses. GalaxySpace was founded in 2016 and is based in Haidian, China.

Aqrose Technology

Series B in 2020
Beijing Aqrose Technology Co., Ltd. is a high-tech company specializing in the research and development of computer vision and robotic technology for industrial automation. Founded in 2017, the company is based in Beijing, China, and leverages artificial intelligence to enhance manufacturing processes. Aqrose Technology offers a range of products, including an artificial intelligence deep learning visual inspection platform known as AIDI, which addresses industrial challenges such as defect detection and classification. The company also provides intelligent robots, like AIPICK, equipped with 3D vision technology and AI-based defect inspection systems. With a founding team originating from the Artificial Intelligence Laboratory of Tsinghua University, Aqrose Technology is committed to advancing industrial automation through innovative machine vision and machine learning solutions, thereby empowering advanced manufacturing and smart logistics sectors in China.

Genskey

Series C in 2020
GensKey is a genetic testing medical diagnostic service provider that applies high-throughput sequencing technology to pathogen diagnosis to solve a series of difficulties in the detection rate, timeliness and accuracy of pathogenic diagnosis, so that many patients with severe infections get timely and accurate. Diagnosis.
Hemu (China) Biological Engineering is a Chinese blood vessel intervention medical equipment firm.

LEADRIVE

Series B in 2020
Leadrive Technology (Shanghai) Co.,Ltd. manufactures homebred power modules and electric vehicle solutions. The company offers products, such as Power Module, Power Control Unit, and Motor. Leadrive Technology (Shanghai) Co.,Ltd. was founded in 2017 and is based in Shanghai, China with additional offices in Shanghai, China; and Aachen, Germany.

Haihe Biopharma

Series B in 2020
HaiHe Biopharma is a developer of innovative anti tumor drugs designed to overcome complex diseases and improve pharmacological evaluation. The company focuses on discovery, development and commercialization of innovative anti-tumor drugs, pharmacological efficacy evaluation and provide products including novel topoisomerase I inhibitors and oral c-Met highly selective inhibitors, enabling customers to improve their health conditions and research quality in an efficient manner.

Tongcheng Shenghuo

Series C in 2020
Tongcheng Life is a community O2O group purchase service platform. With the community as a unit, it establishes a community sales office and completes offline delivery. The platform provides supply, logistics, storage and after-sales support. It mainly provides primary edible agricultural products, food, daily necessities, flowers and gardening, and crafts. , Beauty products and other services.

Uditech

Series B in 2020
Shenzhen Uditech Co., Ltd. develops and manufactures robots for service industry, including restaurants, television, and hospitals. It also manufactures quad core processors. Its robots comprise features, such as face recognition, obstacle avoidance, multi-machine cycle operation, food order and delivery, smart voice, and item transportation. The company was founded in 2013 and is based in Shenzhen, China.

iBeiDiao

Series B in 2020
iBeiDiao is a SaaS background check platform that combines with the Internet.

Wangdiantong

Series B in 2020
Wangdiantong ERP is an enterprise-level e-commerce ERP, supporting Taobao, Tmall, Jingdong, Amazon, Dangdang, No. 1 shop, Alibaba and many other platforms, supporting multi-warehouses, support online stores and physical store cashiers. Including goods management, inventory, orders, purchasing, after-sales, accounts, statistics, CRM and other rich features.

ANYCOLOR

Post in 2020
Ichikara Inc. is an entertainment start-up based in Tokyo, Japan, founded in 2017. The company specializes in creator support and licensing, primarily focusing on the management and operation of virtual streamers associated with the "Nijisanji Project." Ichikara offers a range of services, including access to distribution studios, advertising partnerships, event coordination, and opportunities for program appearances. Additionally, the company actively seeks to discover new talent through auditions, aiming to enhance the virtual entertainment landscape. By leveraging advanced technology, Ichikara strives to create engaging experiences that resonate with audiences globally.

Harbour Biomed

Series B in 2020
Harbour Biomed is a biotechnology company focused on developing bio-therapeutics for immuno-oncology and inflammatory diseases. Established in 2016 and headquartered in Shanghai, with additional operations in Cambridge, Massachusetts, and Rotterdam, the company utilizes two patented transgenic mouse platforms for generating fully human monoclonal antibodies and heavy chain-only bispecific antibodies. These platforms facilitate the creation of innovative therapeutic antibodies, enhancing drug discovery and development processes. Harbour Biomed is actively involved in the development of several candidates, including Batoclimab for autoimmune diseases and Tanfanercept for dry eye disease. The company also collaborates with various institutions and partners to license its antibody platforms, further expanding its reach in the biotechnology sector.

Genskey

Series B in 2020
GensKey is a genetic testing medical diagnostic service provider that applies high-throughput sequencing technology to pathogen diagnosis to solve a series of difficulties in the detection rate, timeliness and accuracy of pathogenic diagnosis, so that many patients with severe infections get timely and accurate. Diagnosis.

Lunit

Series C in 2020
Lunit Inc. is a South Korean company that specializes in developing advanced algorithms for medical image analysis and general object detection using machine learning technology. The firm focuses on areas such as digital chest X-ray, digital mammography, digital pathology, and fundus photography. By leveraging cutting-edge deep learning techniques, Lunit aims to assist physicians in making accurate and efficient clinical decisions. The company has demonstrated its expertise in image recognition, having ranked among the top five in the ImageNet Challenge, a prominent competition in the field. Lunit's technology is notable for its ability to utilize weakly labeled data, enhancing its pattern recognition capabilities. Supported by significant venture capital investments, Lunit is actively engaged in large-scale research collaborations with major university hospitals in South Korea, reflecting its strong reception within the medical community.

Nanovision Technology

Series B in 2019
Nanovision Technology is located in Zhongguancun Yongfeng high-tech industrial base, with thousands of square meters of R&D foundation in Yonyou Industrial Park. We also set up a subsidiary company in Chengdu. their company is a high-tech enterprise focused on high-speed and high-precision radiology imaging.Nanovison focus in static CT,x-ray CMOS detectors and x-ray imaging software, etc.Which can be widely used in medical, industrial, security and other fields.

Dongfang Weiyin

Series C in 2019
Dongfang Weiyin is a financial service platform focused on small and micro enterprises. Established in 2015 and headquartered in Beijing, China, the company specializes in developing DFWYBANK.com, an accounting and tax database solution tailored for banks, tax bureaus, and small to medium-sized businesses. Through its services, Dongfang Weiyin aims to enhance financial management and compliance for its clients, contributing to the growth and sustainability of smaller enterprises in the Chinese market.

Suzhou Ribo Life Science

Series C in 2019
Suzhou Ribo Life Science is a developer of RNA interference ( RNAi ) technology designed to treat liver diseases. The company's RNA interference ( RNAi ) technology is used to develop nucleic acid therapeutic drugs and related products, enabling healthcare providers to deliver more effective pharmaceuticals to patients.

RT-Thread

Series B in 2019
RT-Thread develops an open source real-time operating system for embedded devices. The company offers an autonomous Internet of Things operating system with features, such as cross-chip platform, real-time operating system kernel, cloud integration, ultra-low power design, quick start, security design, intelligent AI engine, and open platform, stable and reliable, rich components, easy to use, and scalable. Its integrated design of the device and cloud enables easy access to all major IoT device cloud platforms. The company’s system also offers functions, such as device virtual file system, device manager framework, low-power management framework, protocol stack, audio streaming framework, firmware remote upgrade FOTA, and third-party components. It serves new energy, electricity, consumption, home appliances, and transportation industries. The company was founded in 2006 and is based in Shanghai, China.

Xbiome

Series B in 2019
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

Gambol Pet Group

Series B in 2019
Gambol Pet Group Co., Ltd manufacturers pet food. Its Products categories includes: pet treats series which made of chicken jerky, duck jerky, pork, lamb and fish, wet pet food with ingredient of meat and fruits and vegetables, and dog food with nutritional supplements, natural ingredients. It ships products to Europe, Asia, North America. Gambol Pet Group Co., Ltd was founded in 2006 and is headquartered in Liaocheng City, China.

dMed

Series B in 2019
dMed Company Limited, also known as, dMed Biopharmaceutical Co., Ltd. operates as clinical contract research organization providing services for development of medicines and medical devices. The company offer services, including consulting, clinical operations, biostatistics & programming, data management, pharmacovigilance, clinical science & medical affairs, quality assurance, and regulatory affairs & Strategy. It serves biopharmaceutical and medical device companies. dMed Company Limited was founded in 2016 and is based in Shanghai, China.

Mathpresso, Inc.

Series B in 2019
Mathpresso, Inc. is an educational technology company based in Seoul, South Korea, established in 2015. It operates Qanda, a data-driven platform that leverages artificial intelligence and optical character recognition (OCR) technology to assist students with their studies. Users can take a photo of a question or problem, which the platform then analyzes to provide solutions and explanations. Qanda covers a wide range of subjects, including mathematics, Korean history, social studies, and science. The platform is designed to facilitate learning by allowing students to engage with tutors and access answers in real time. As of this year, Qanda has attracted over one million users in South Korea, making it a significant resource for students seeking help with homework and exam preparation.

GalaxySpace

Series B in 2019
GalaxySpace develops and builds LEO broadband satellite constellation, and 5G communication network. The company’s satellite applications include monitoring of airport, parking, and oil reserves, as well as assess land types and uses. GalaxySpace was founded in 2016 and is based in Haidian, China.

GKHT Medical Technology

Series C in 2019
Guoke Hengtai (Beijing) Medical Technology Co., Ltd. was established in February 2013 and is affiliated to Oriental Science and Technology Holding Group Co., Ltd. (hereinafter referred to as “Oriental Instrument”), a subsidiary of the State-owned Assets Supervision and Administration Commission of the Chinese Academy of Sciences. It is headquartered in Yizhuang Economic and Technological Development Zone, Beijing. . Since the establishment of Guoke Hengtai for 4 years, the company has experienced two rounds of investment in A and B, and its performance has continued to grow at a high speed, with a compound annual growth rate of over 50%. In 2017, the company officially launched the IPO listing journey.

AgotoZ

Series B in 2019
AgotoZ Technology provides a network transmission intelligent platform with the capabilities of resource calculation and security defense. Established in 2017, Guanmai Technology (Beijing) Co., Ltd. is a leading WAN high-speed transmission core technology, big data computing technology, security defense technology, and accelerates its core technologies and products through independent research and development, focusing on providing high-speed and efficient enterprises. Interoperability platform and related solutions.

Tongcheng Shenghuo

Series B in 2019
Tongcheng Life is a community O2O group purchase service platform. With the community as a unit, it establishes a community sales office and completes offline delivery. The platform provides supply, logistics, storage and after-sales support. It mainly provides primary edible agricultural products, food, daily necessities, flowers and gardening, and crafts. , Beauty products and other services.

Inossem

Series B in 2019
Nanjing Inossem Software Technology Co., Ltd. provides enterprise application product development and consulting services. The company offers enterprise consulting services that include IT planning, supply chain consulting, ERP consulting, etc. It also focus on material management field of enterprises, and develops intelligent storage (Instock) and intelligent master data (Indata) based on the technical foundation of AI and IoT. The company was founded in 2015 and is based in Nanjing, China. It has additional offices in Canada, the United Kingdom, China, and Hong Kong.

Shuhai Supply Chain

Series B in 2019
Shuhai Supply Chain Logistics is a supply chain service enterprises that provides overall ingredients supply chain solutions services. It has a nationwide modern cold chain logistics center, food processing plants, and other bases. Bohai has been recognized by the industry authorities and customers, has become the benchmark enterprises in the field of supply chain. Founded in June 2011, the company is headquartered in Beijing, China.

Jiangrongxin Technology

Series B in 2019
Developer of financial and marketing software for consumer financial services enterprises. The company's credit card core system helps card issuers manage cardholder's credit and incentives, while their marketing platform can make purchase recommendations to consumers and track user retention.

River Security

Series B in 2019
Silicon Security, founded in 2012, focuses on providing the industry's cutting edge Internet dynamic application security solution. Headquartered in Shanghai, Beijing and Shenzhen, respectively, with branches, and set up a research and development center in Chengdu. Ruimin information after more than two years of research and development, developed a global leader in the leading active defense security technology. The technology completely subvert the traditional continuation of more than 20 years of security technology base, can defend against a variety of unknown modern means of attack, blocking more efficient, more timely, while significantly reducing deployment and use costs.

Zongmu

Series C in 2019
ZongMu Technology was founded in January 2013. Headquartered in Pudong ZhangJiang high-tech park of Shanghai, ZongMu has RD centers in Beijing and ShenZhen respectively. Through its innovative solution and excellent service to the local market, ZongMu has shipped multiple SurroundView ADAS (Advanced Driving Assistance System) in main stream OEM automotive markets, becoming the leading SurroundView ADAS solution vendor for China domestic market and formed strategic partnership with multiple OEM car makers and their tier1 suppliers.

Deepwise

Series C in 2019
Shenzhen Rui Medica is an artificial intelligence technology-based clinical imaging services provider. The company focuses on the development of clinical imaging diagnosis system for early-stage detection of cancer. Its services covers breast cancer, prostate cancer, and chest radiograph.

Bangsun Technology

Series C in 2019
Hangzhou Bangsun Financial Information Technology Ltd. develops online payment security software to domestic Internet trading companies and online financial institutions. The company offers solution, such as banking solution, tripartite payment solution, bank card solution, credit card, securities, and e-government solutions. In addition, it provides products, including real time transaction anti-fraud, Internet credit, flow cube, machine learning system and model, device fingerprint, machine defense service, Internet risk data service, and anti-money laundering service. Hangzhou Bangsun Financial Information Technology Ltd. was founded in 2010 and is based in Hangzhou, China.

New Horizon Health

Series C in 2019
New Horizon Health, founded in 2015 and headquartered in Hangzhou, China, specializes in developing advanced technologies for the detection and screening of gastrointestinal cancers, particularly gastric and colorectal cancers. The company offers innovative products based on fecal gene analysis (FIT-DNA) technology, enabling users to conduct at-home tests that identify signs of colon cancer and significant adenomas. This technology facilitates earlier detection of precancerous lesions compared to conventional blood tests. By leveraging big data and artificial intelligence, New Horizon Health enhances its cancer screening solutions, aiming to improve public health outcomes. The company also emphasizes its commitment to making early cancer screening accessible to households, thereby striving to reduce the incidence and mortality associated with cancer.

Black Sesame Technologies

Series B in 2019
Black Sesame Intelligent Technology Co., Ltd. an artificial intelligence company, develops digital imaging technology. The company was founded on July 2016 and is based in China.

Likechuxing

Series B in 2019
Traveling immediately is a car sharing travel service platform taking advantage of the tide of sharing economy. By deep integration of mobile Internet and car time-sharing, it breaks the traditional car travel mode and serves the needs of short-haul travel within the city. Travel APP immediately combines the depth of the mobile Internet with the time-sharing of cars. The user can realize the intelligent operation of the whole process of the car at any time through the APP, and only need to bear the mileage and long-term cost. “Travel immediately” changed the way traditional car trips and car rentals.
Shanghai Cell Therapy Group Co., Ltd., established in 2013 and headquartered in Shanghai, China, specializes in the field of cell therapy technology. The company provides technical services and consulting, as well as technology transfer and investments within the healthcare sector. It operates a cellular diagnosis center that integrates cellular research and treatment services, focusing on areas such as cellular cold storage and cellular pharmaceuticals. Additionally, Shanghai Cell Therapy Group facilitates genetic testing for patients and supports cancer facilities by supplying essential research data.

SAFE Pharmaceutical

Series C in 2018
Beijing Saifu Medical Research Institute Co., Ltd. relies on the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and the National Drug Safety Evaluation and Research Center of the State of Beijing to establish strategic partnerships with them to form a combination of technology, capital and enterprise operations. The core members of the company are researchers of the Institute of Materia Medica of the Chinese Academy of Sciences and researchers of the Academy of Military Medical Sciences. They have high scientific research and academic status in the fields of drug research and development and toxicology research, as well as rich drug development, GLP management and technical experience, and build and operate the platform. Provides strong talent and technical support.
Shanghai Cell Therapy Group Co., Ltd., established in 2013 and headquartered in Shanghai, China, specializes in the field of cell therapy technology. The company provides technical services and consulting, as well as technology transfer and investments within the healthcare sector. It operates a cellular diagnosis center that integrates cellular research and treatment services, focusing on areas such as cellular cold storage and cellular pharmaceuticals. Additionally, Shanghai Cell Therapy Group facilitates genetic testing for patients and supports cancer facilities by supplying essential research data.

Akulaku

Series C in 2018
Akulaku Inc. is a consumer finance platform based in Jakarta, Indonesia, established in 2016. The company specializes in offering online financial credit services to customers across Southeast Asia. Its services include shopping in installments through an independently managed online marketplace and various other platforms, as well as providing flexible cash loans. Akulaku's mission is to enhance the quality of life for both partners and consumers by creating a comprehensive and reliable financial ecosystem.

Udesk

Series C in 2018
Udesk Ltd. operates as a customer experience solution provider The company omnichannel communication, a platform that integrates call center, online customer service, and work order system, connects different communication channels, and connects global customers; text conversation robot, voice robot, agent assistant, and quality inspection; cover multiple application scenarios, deployment of multiple solutions, and security architecture; sales cloud, field service cloud, customer service and complaint management system, and business intelligence analysis. It serves to health, Internet, hotel, retail, logistics, manufacturing, real estate, legal, education, automobile, insurance, and banking industry. The company was founded in 2014 and is based in Beijing, China.

Zhenkunhang

Series C in 2018
Zhenkunhang, also known as Qingdao Zhenkun Trading, is an e-commerce platform for industrial products, including maintenance, operation, and repair (MRO) products. Zhenkunhang was founded in 1996. Qingdao Zhenkun Trading is a professional lubricant, adhesive, fasteners, and related equipment suppliers, is committed to providing customers with a full range of bonding and sealing, lubrication, fastening solutions. We work with a number of internationally renowned brands to creatively combine different suppliers and our own unique technologies and products to provide our customers with the most suitable solutions. Fastener products cover all types of fasteners in the world today, mainly including: hexagon socket head cap screws, hexagonal screws, stop screws (top screws), various mechanism screws, self tapping screws, nuts, various washers, Rivets, pins, splines, tools for the above products, nylon lock (tie), etc., and we offer products of different materials (carbon steel, stainless steel, copper, aluminum) We can provide DIN, ISO, NFE, JIS, ANSI, BS, GB different brand and non-brand fasteners according to your requirements.

Harbour Biomed

Series B in 2018
Harbour Biomed is a biotechnology company focused on developing bio-therapeutics for immuno-oncology and inflammatory diseases. Established in 2016 and headquartered in Shanghai, with additional operations in Cambridge, Massachusetts, and Rotterdam, the company utilizes two patented transgenic mouse platforms for generating fully human monoclonal antibodies and heavy chain-only bispecific antibodies. These platforms facilitate the creation of innovative therapeutic antibodies, enhancing drug discovery and development processes. Harbour Biomed is actively involved in the development of several candidates, including Batoclimab for autoimmune diseases and Tanfanercept for dry eye disease. The company also collaborates with various institutions and partners to license its antibody platforms, further expanding its reach in the biotechnology sector.

Urotronic

Series B in 2018
Urotronic, Inc. is a medical device company based in Plymouth, Minnesota, founded in 2014. The company specializes in developing innovative solutions for urology, particularly in the treatment of urethral blockages. Its flagship product, Optilume, is a drug-coated balloon catheter designed to treat urethral strictures in men. This device combines balloon dilation with localized drug delivery, utilizing the drug paclitaxel to inhibit cell proliferation and reduce the formation of scar tissue that can lead to stricture recurrence. By effectively covering the affected area during the procedure, Optilume offers a low-cost, minimally-invasive treatment option for patients suffering from urinary tract conditions, catering primarily to urologists and their patients.

Spacety

Series B in 2018
Spacety is a microsatellite start-up that specializes in developing commercial micro/nano-satellites. It provides short-cycle, low-cost, and one-stop services to scientists, research institutes, and commercial companies, for science experiments and technology demonstrations. At present, the company has launched four commercial microsatellites and aims for more in the future. The company was founded in January 2016 with headquarters in Changsha, China.

Lunit

Series B in 2018
Lunit Inc. is a South Korean company that specializes in developing advanced algorithms for medical image analysis and general object detection using machine learning technology. The firm focuses on areas such as digital chest X-ray, digital mammography, digital pathology, and fundus photography. By leveraging cutting-edge deep learning techniques, Lunit aims to assist physicians in making accurate and efficient clinical decisions. The company has demonstrated its expertise in image recognition, having ranked among the top five in the ImageNet Challenge, a prominent competition in the field. Lunit's technology is notable for its ability to utilize weakly labeled data, enhancing its pattern recognition capabilities. Supported by significant venture capital investments, Lunit is actively engaged in large-scale research collaborations with major university hospitals in South Korea, reflecting its strong reception within the medical community.

Aikucun

Series B in 2018
Aikucun is a sales distribution company that provides fast and controllable inventory sales channels. As the micro-business purchasing channels have a certain privacy, completely independent of the traditional sales channels, and will not affect the brand's existing sales system. The brand owner can easily complete the inventory sales simply by sharing the inventory. Founded in 2017 by Shanghai Zhongdan Information Technology Co., Ltd., Aikucun is a crowdsourcing distribution platform.

Zongmu

Series C in 2018
ZongMu Technology was founded in January 2013. Headquartered in Pudong ZhangJiang high-tech park of Shanghai, ZongMu has RD centers in Beijing and ShenZhen respectively. Through its innovative solution and excellent service to the local market, ZongMu has shipped multiple SurroundView ADAS (Advanced Driving Assistance System) in main stream OEM automotive markets, becoming the leading SurroundView ADAS solution vendor for China domestic market and formed strategic partnership with multiple OEM car makers and their tier1 suppliers.

Paixue Che

Series B in 2018
Pai Xueche is an Internet driving training platform. The school adopts a consultant tracking system throughout the process. The company will equip each student with an exclusive learning car consultant, from registration to the student's driver's license, the whole process of tracking.

Taihe Music Group

Series C in 2018
Taihe Music Group is a global music service provider and record label producer that provides artist services, copyright management, audio-visual services and live performance.

Enjoy Dental Clinic

Series B in 2018
Enjoy Dental Clinic provides dental care services. The company was founded in 2007 and is based in Beijing, China.

Nattitude

Series B in 2018
An E-commerce Platform based in Guangzhou,China.

Jollychic

Series C in 2018
Jollychic EC Limited is an online retail platform that offers a diverse range of products, including clothing, shoes, bags, baby items, electronics, home goods, and various accessories. Established in 2012 and headquartered in Birkirkara, Malta, Jollychic aims to provide customers with a convenient shopping experience through its extensive selection of stylish and quality products. The platform features categories such as apparel, sports goods, toys, bedding, wedding supplies, cleaning tools, and kitchen appliances, making it a comprehensive destination for consumers seeking a variety of goods in one place.

NewsDog

Series C in 2018
NewsDog operates as a news and entertainment content aggregator, focusing on both Indian and international markets. The company has developed a platform known as WeMedia, which facilitates content submission from users and has garnered a community of over 30,000 regular contributors. By leveraging machine learning technology, NewsDog curates personalized news experiences for its users, allowing them to access updated information efficiently. The company faces competition from other content aggregators, including Dailyhunt, Inshorts, and NewsPoint.

Uoko.com

Series C in 2018
Uoko.com, operated by Sichuan UOKO Investment Management Co. Ltd., is a prominent player in the apartment rental sector in China, particularly targeting second-tier cities like Chengdu and Wuhan. Established in 2012 and headquartered in Chengdu, the company specializes in offering standardized rental apartments tailored for young students and professionals. Uoko.com positions itself within the sharing economy by providing comprehensive house management solutions that benefit property owners while also delivering high-quality, long-term rental options for urban residents. Additionally, the platform emphasizes community engagement through various after-sales services that enhance the living experience for tenants.

Uditech

Series B in 2018
Shenzhen Uditech Co., Ltd. develops and manufactures robots for service industry, including restaurants, television, and hospitals. It also manufactures quad core processors. Its robots comprise features, such as face recognition, obstacle avoidance, multi-machine cycle operation, food order and delivery, smart voice, and item transportation. The company was founded in 2013 and is based in Shenzhen, China.

Deepwise

Series B in 2018
Shenzhen Rui Medica is an artificial intelligence technology-based clinical imaging services provider. The company focuses on the development of clinical imaging diagnosis system for early-stage detection of cancer. Its services covers breast cancer, prostate cancer, and chest radiograph.

INXX

Series B in 2018
Hangzhou INXX Fashion Co,. Ltd. retails apparels and accessories through the Internet. The company is based in Hangzhou, China.